HK1202899A1 - 糖尿病的生物標誌物 - Google Patents

糖尿病的生物標誌物

Info

Publication number
HK1202899A1
HK1202899A1 HK15103388.7A HK15103388A HK1202899A1 HK 1202899 A1 HK1202899 A1 HK 1202899A1 HK 15103388 A HK15103388 A HK 15103388A HK 1202899 A1 HK1202899 A1 HK 1202899A1
Authority
HK
Hong Kong
Prior art keywords
biomarkers
diabetes
Prior art date
Application number
HK15103388.7A
Other languages
English (en)
Inventor
陳重娥
蘇詠儀
馬青云
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Publication of HK1202899A1 publication Critical patent/HK1202899A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15103388.7A 2012-01-27 2015-04-03 糖尿病的生物標誌物 HK1202899A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261591598P 2012-01-27 2012-01-27
PCT/CN2013/071053 WO2013110245A1 (en) 2012-01-27 2013-01-28 Biomarkers for diabetes

Publications (1)

Publication Number Publication Date
HK1202899A1 true HK1202899A1 (zh) 2015-10-09

Family

ID=48872882

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103388.7A HK1202899A1 (zh) 2012-01-27 2015-04-03 糖尿病的生物標誌物

Country Status (4)

Country Link
US (1) US10689702B2 (zh)
CN (1) CN104395479B (zh)
HK (1) HK1202899A1 (zh)
WO (1) WO2013110245A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3067713A1 (en) * 2017-06-28 2019-01-03 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Method for determining the risk to develop type 1 diabetes
CN110527717B (zh) * 2018-01-31 2023-08-18 完美（广东）日用品有限公司 用于2型糖尿病的生物标志物及其用途
US11064942B1 (en) 2018-05-04 2021-07-20 Optum Labs, Llc Methods and systems to detect eating
US20210254164A1 (en) * 2018-06-15 2021-08-19 Opti-Thera Inc. Polygenic risk scores for predicting disease complications and/or response to therapy
US11185260B1 (en) 2018-08-14 2021-11-30 Optum Labs, Llc State-based methods and systems using continuous glucose monitors and accelerometers to regulate glucose levels
CN112635049A (zh) * 2020-12-23 2021-04-09 无锡市第二人民医院 一种研究HSD17B13 rs72613567基因变异和肾功能损伤之间关系的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248527B1 (en) * 1998-10-21 2001-06-19 Millennium Pharmaceuticals, Inc. Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E
CN100540678C (zh) * 2004-04-15 2009-09-16 香港中文大学 应用遗传标记和芯片预测糖尿病肾病危险的方法
WO2008065544A2 (en) * 2006-09-11 2008-06-05 Mcgill University Genetic predictors of risk for type 2 diabetes mellitus

Also Published As

Publication number Publication date
US10689702B2 (en) 2020-06-23
WO2013110245A1 (en) 2013-08-01
CN104395479A (zh) 2015-03-04
CN104395479B (zh) 2019-03-15
US20150045238A1 (en) 2015-02-12

Similar Documents

Publication Publication Date Title
HK1207122A1 (zh) 糖尿病生物標志物及其應用
GB201213567D0 (en) Biomarkers
EP2885640A4 (en) CANCER DIAGNOSTICS USING BIOMARKERS
GB201211982D0 (en) Biomarker
ZA201409006B (en) Diabetes biomarkers
EP2897614A4 (en) CMPF ACID AS A BIOMARKER FOR DIABETES AND ASSOCIATED METHODS
EP2850078A4 (en) BENZOPYRYLIUMVERBINDUNGEN
EP2828282A4 (en) BIOMARKERS
HK1202899A1 (zh) 糖尿病的生物標誌物
EP2844773A4 (en) ANALYSIS OF BIOMARKERS USING SCODAPHORESIS
EP2836845A4 (en) MATERNAL BIOMARKERS FOR GESTATIONAL DIABETES
GB2504567B (en) Anti-Relatch Mechanism
GB201210565D0 (en) Biomarkers
SG11201502390QA (en) Biomarkers for down syndrome prenatal diagnosis
PL2626134T3 (pl) Pipeta
HK1207664A1 (zh) 糖尿病生物標誌物及其應用
EP2838540A4 (en) BIOMARKERS FOR MONITORING INTERVENTIONIST ANTIDIABETIC THERAPIES
GB201117172D0 (en) Diabetes
GB201104556D0 (en) Biomarkers
GB201113968D0 (en) Prognostic methadology
EP2864782A4 (en) BIOMARKERS OF DEMENTIA WITH NEUROFIBRILLARY DEGENERATION
GB201209802D0 (en) Biomarker
GB201202944D0 (en) Biomarker
GB201210587D0 (en) Predictive biomarker
HK1216926A1 (zh) 免疫檢測